Electro Optic Systems Holdings Limited (EOS.AX) stock analysis: Buy

Bro's Verdict
Deep Dive

Rating

BUY

Confidence

65%

Target Price

A$13.00

Upside

+30.2%

Horizon

medium

EOS offers a compelling turnaround story with a record $459m order book (+237% YoY) underpinning 87-110% FY26 revenue growth guidance and an expected EBITDA inflection to positive in 1H26. The net cash balance sheet provides flexibility to scale production without dilution risk, and the 12-month target of $13.00 implies ~30% upside from current levels. However, the call carries meaningful execution risk given the company's history of operational underperformance and negative forward EPS, warranting a moderate confidence rating.

Executive Summary

•Record order book of $459m (+237% YoY) with 18 new contracts worth ~$420m secured in 2025 provides strong revenue visibility and underpins the guidance upgrade to $240-270m for FY26, an 87-110% increase on FY25 continuing operations revenue of $128.5m

•Company is at an EBITDA inflection point, with management guiding to positive underlying EBITDA in 1H26, a significant turnaround from historical losses and the negative TTM net margin of -24.1%

•Net cash position (Net Debt/EV of -0.08x) provides balance sheet flexibility to fund working capital and production scale up without dilution risk, a critical advantage for a defence contractor entering a high growth phase

•Stock trades at ~7x TTM P/S and ~6x forward P/S on consensus revenue, pricing in significant execution but remaining below the $13.64 consensus target, suggesting ~37% upside if guidance is delivered

Financial Snapshot

•Revenue (TTM): $253.2m

•Revenue (FY25 continuing operations): $128.5m

•Gross margin: 57.4%

•Operating margin: 3.4%

•Net margin: -24.1%

•ROE: -18.9% (TTM)

•Debt/Equity: 21.7%

•Net Debt/EV: -0.08x (net cash position)

•Shares on issue: 221.7m

•Order book: $459m (record, +237% YoY)

•Market cap: ~$2.2b at current price

Forward Outlook

•Revenue guidance FY26: $240m to $270m (+87% to +110% YoY on continuing operations)

•Consensus revenue (NTM): ~$309m

•Underlying EBITDA: Expected positive in 1H26, versus a forecast $9.9m loss previously

•Consensus EBIT (NTM): Not reliably disclosed given conflicting data points

•Forward EPS (NTM): -$0.18, reflecting continued investment and overhead absorption during production ramp

•EBITDA growth: +1.4% (consensus), expected to accelerate as revenue scales

•Margin trajectory: Gross margins likely to hold in the 55-60% range; operating margins should expand materially as fixed costs are leveraged across a doubling revenue base, though positive operating income may not materialise until 2H26 or FY27

Valuation Analysis

•NTM P/E: Not meaningful (negative forward EPS of -$0.18)

•TTM P/S: ~7.2x ($2.2b market cap / $253.2m TTM revenue)

•NTM P/S: ~5.9x (on consensus revenue of ~$309m)

•NTM P/S (guidance midpoint): ~8.1x (on $255m guidance midpoint)

•EV: ~$1.38b (per Bloomberg data, reflecting net cash adjustment)

•NTM EV/EBITDA: Not reliably calculable given negative EBITDA history and limited forward visibility

•DCF: WACC 9.5%, terminal growth 2.5%; with revenue reaching $350-400m by FY28 and EBITDA margins normalising to 12-15%, fair value range of $10.50 to $14.00 per share

•Consensus target price: $13.64 (~37% upside from $9.98)

Peer Comparisons:

•CDA (Codan): ~25x NTM P/E, ~4x NTM P/S, defence electronics exposure, profitable

•ASB (Austal): ~20x NTM P/E, ~0.7x NTM P/S, shipbuilding, lower margins

•LHX (L3Harris): ~20x NTM P/E, ~3x NTM P/S, diversified defence, stable margins

•DRO (DroneShield): ~35x NTM P/E, ~12x NTM P/S, defence tech peer, high growth

Key Risks & Catalysts

Risks:

•Execution risk on $459m order book delivery, particularly given history of production delays and cost overruns

•Negative forward EPS of -$0.18 indicates the company is still loss making at the net income level despite revenue growth

•Key customer concentration risk with US defence contracts, including the US$22m deal referenced in recent announcements

•Operating margin of only 3.4% TTM shows significant overhead burden that could persist if revenue ramp disappoints

•Geopolitical risk shifts could alter defence spending priorities, particularly around counter drone and directed energy weapon programmes

•Stock has retraced ~21% from 52 week high of $12.58, suggesting momentum has cooled

•Cash from operations at -24.18x (Bloomberg signal) indicates working capital intensive phase as production scales

Catalysts:

•1H26 results confirmation of positive EBITDA would be a material de-risking event and could drive re rating

•Additional large contract wins from US DoD or allied governments, particularly in remote weapon systems and high energy laser programmes

•Progress toward positive net income, likely FY27 based on current trajectory

•Potential inclusion in ASX 300 index given market cap expansion

•Reassessment of consensus estimates upward if FY26 revenue tracks toward the upper end of $240-270m guidance

•Directed energy weapon commercialisation milestones, a differentiated technology with limited listed peers

Investment Thesis

EOS presents a compelling but high risk turnaround story in the Australian defence technology sector. The record $459m order book, up 237% YoY, provides unprecedented revenue visibility for a company of this size, and the guidance for 87-110% revenue growth in FY26 represents a genuine inflection. The net cash balance sheet is a critical strength, allowing the company to fund working capital and production scale up without the dilution or solvency risks that typically plague defence contractors during growth phases. The shift to positive underlying EBITDA in 1H26, if delivered, would mark the transition from a cash burning development story to a scalable manufacturing business.

However, the valuation already prices in substantial improvement. At ~6x forward P/S on consensus revenue, EOS trades at a premium to most established defence contractors, justified only by its superior growth rate and technology differentiation in directed energy weapons and remote weapon systems. The negative forward EPS and history of operational underperformance create execution risk that cannot be ignored. The gap between TTM revenue ($253.2m) and FY25 continuing operations ($128.5m) also warrants scrutiny regarding discontinued operations and accounting clarity.

We rate EOS as a speculative buy with a 12 month target of $13.00, aligning closely with the $13.64 consensus target. The thesis hinges on three things: delivery against the order book, EBITDA positivity in 1H26, and margin expansion as fixed costs leverage. A pullback toward $8.00-8.50 would offer a more attractive entry point with better risk reward, particularly given the stock's 21% retracement from highs and the negative forward EPS. Position sizing should reflect the binary nature of defence contract execution and the company's history of disappointing on timelines.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Electro Optic Systems Holdings Limited EOS.AX

Bro's Verdict
Deep Dive

Executive Summary

Financial Snapshot

Forward Outlook

Valuation Analysis

Key Risks & Catalysts

Investment Thesis

Run your own analysis free

Bro's VerdictDeep Dive

Executive Summary

Financial Snapshot

Forward Outlook

Valuation Analysis

Key Risks & Catalysts

Investment Thesis

Run your own analysis free

Bro's Verdict
Deep Dive